Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients

Nephrology

Volumn 18, Issue 11, 2013, Pages 736-742

  Tu, Guo Wei ^a   Ju, Min Jie ^a   Xu, Ming ^a   Rong, Rui Ming ^a   He, Yi Zhou ^a   Xue, Zhang Gang ^a   Zhu, Tong Yu ^a   Luo, Zhe ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

caspofungin; Pneumocystis jirovecii pneumonia; renal transplantation

Indexed keywords

CARBON DIOXIDE; CASPOFUNGIN; COTRIMOXAZOLE; LACTATE DEHYDROGENASE; LIVER ENZYME; MERCURY; METHENAMINE; METHYLPREDNISOLONE; MOXIFLOXACIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; ECHINOCANDIN;

ADULT; ANAMNESIS; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; ARTICLE; ARTIFICIAL VENTILATION; CARBON DIOXIDE TENSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; EMPHYSEMA; EXTRACORPOREAL OXYGENATION; FOLLOW UP; GRAFT RECIPIENT; HEMODYNAMIC STRESS; HUMAN; HYPERBILIRUBINEMIA; HYPOXEMIA; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY TRANSPLANTATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG INFILTRATE; LUNG LAVAGE; MAINTENANCE DRUG DOSE; MALE; NEUTROPHIL COUNT; OXYGEN SATURATION; OXYGEN TENSION; PH; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SHOCK; SILVER STAINING; SUBCUTANEOUS EMPHYSEMA; THORAX RADIOGRAPHY; DRUG COMBINATION; MIDDLE AGED; PNEUMONIA, PNEUMOCYSTIS;

ADULT; DRUG THERAPY, COMBINATION; ECHINOCANDINS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 84886489477     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12133     Document Type: Article

References (16)

1. Sepkowitz KA,. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin. Infect. Dis. 2002; 34: 1098-1107.
2. Gerrard JG,. Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults. Med. J. Aust. 1995; 162: 233-235.
3. Radisic M, Lattes R, Chapman JF, et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: A case-control study. Transpl. Infect. Dis. 2003; 5: 84-93.
4. Kamboj M, Weinstock D, Sepkowitz KA,. Progression of Pneumocystis jirovecii pneumonia in patients receiving echinocandin therapy. Clin. Infect. Dis. 2006; 43: e92-94.
5. Hof H, Schnulle P,. Pneumocystis jirovecii pneumonia in a patient with Wegener's granulomatosis treated efficiently with caspofungin. Mycoses 2008; 51 (Suppl 1): 65-67.
6. Utili R, Durante-Mangoni E, Basilico C, Mattei A, Ragone E, Grossi P,. Efficacy of caspofungin addition to trimethoprim-sulfamethoxazole treatment for severe pneumocystis pneumonia in solid organ transplant recipients. Transplantation 2007; 84: 685-688.
7. Beltz K, Kramm CM, Laws HJ, et al. Combined trimethoprim and caspofungin treatment for severe Pneumocystis jirovecii pneumonia in a five-year-old boy with acute lymphoblastic leukemia. Klin. Padiatr. 2006; 218: 177-179.
8. Annaloro C, Della Volpe A, Usardi P, Schroten H, Wessalowski R, Göbel U,. Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation. Eur. J. Clin. Microbiol. Infect. Dis. 2006; 25: 52-54.
9. Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary. Kidney Int. 2010; 77: 299-311.
10. Chadban SJ, Barraclough KA, Campbell SB, et al. KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Nephrology 2012; 17: 204-214.
11. Thomas CF, Jr, Limper AH,. Pneumocystis pneumonia. N. Engl. J. Med. 2004; 350: 2487-2498.
12. Takahashi T, Hosoya N, Endo T, et al. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. J. Clin. Microbiol. 2000; 38: 3161-3164.
13. Nahimana A, Rabodonirina M, Helweg-Larsen J, et al. Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia. Emerg. Infect. Dis. 2003; 9: 864-867.
14. Armstrong-James D, Stebbing J, John L, et al. A trial of caspofungin salvage treatment in PCP pneumonia. Thorax 2011; 66: 537-538.
15. Kim T, Hong HL, Lee YM, et al. Is caspofungin really an effective treatment for Pneumocystis jirovecii pneumonia in immunocompromised patients without human immunodeficiency virus infection? Experiences at a single center and a literature review. Scand. J. Infect. Dis. 2013; 45: 484-488.
16. Cushion MT, Linke MJ, Ashbaugh A, et al. Echinocandin treatment of pneumocystis pneumonia in rodent models depletes cysts leaving trophic burdens that cannot transmit the infection. PLoS ONE 2010; 5: e8524.